SLF
REGN icon

Sun Life Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Sun Life Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-63
Closed -$30K – 404
2021
Q1 		$30K Hold
63
– – ﹤0.01% 215
2020
Q4 		$30K Buy
63
+1
+2% +$540 ﹤0.01% 210
2020
Q3 		$35K Buy
62
+2
+3% +$1.21K 0.01% 188
2020
Q2 		$37K Buy
60
+12
+25% +$6.81K 0.01% 163
2020
Q1 		$23K Buy
48
+1
+2% +$412 0.01% 186
2019
Q4 		$18K Sell
47
-18
-28% -$6.06K ﹤0.01% 228
2019
Q3 		$18K Buy
65
+1
+2% +$296 ﹤0.01% 412
2019
Q2 		$20K Sell
64
-69
-52% -$23K 0.01% 394
2019
Q1 		$55K Sell
133
-81
-38% -$33.4K 0.01% 345
2018
Q4 		$80K Buy
214
+3
+1% +$1.1K 0.02% 322
2018
Q3 		$85K Buy
211
+1
+0.5% +$381 0.02% 350
2018
Q2 		$72K Buy
210
+89
+74% +$27.8K 0.01% 369
2018
Q1 		$351 Sell
121
-47
-28% -$16.3K ﹤0.01% 462
2017
Q4 		$63K Sell
168
-397
-70% -$161K 0.01% 236
2017
Q3 		$253K Buy
565
+25
+5% +$11.9K 0.03% 198
2017
Q2 		$265K Buy
540
+524
+3,275% +$229K 0.03% 187
2017
Q1 		$41 Buy
16
+1
+7% +$371 ﹤0.01% 524
2016
Q4 		$40 Buy
+15
New +$5.7K ﹤0.01% 473

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sun Life Financial's REGN Position: Q2 2021 in Review

Sun Life Financial sold out of Regeneron Pharmaceuticals (REGN) in Q2 2021, closing a stake of 63 shares — an estimated $30K sold.

Sun Life Financial first reported a position in REGN in Q4 2016 and held it in 18 quarters. The position peaked at $265K in Q2 2017. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

  • Sun Life Financial reported no remaining Regeneron Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sun Life Financial sold 63 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $30K.
  • Sun Life Financial first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 18 quarters.
  • Sun Life Financial's Regeneron Pharmaceuticals position peaked at $265K in Q2 2017.
  • 971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on Sun Life Financial's 13F filing for Q2 2021, filed 10 Aug 2021.